A convenient method for measuring the release of gut glucagon-like immunoreaetivity (GLI) from rat jejunal pieces incubated 'in vitro' is described. The method utilises Trasylol, EDTA, and excessive glueagon antibody to prevent GLI breakdown. There was satisfactory recovery of added pancreatic glucagon to the incubates, and a highly significant release of GLI was recorded when high glucose concentrations (5--40 g%) were incubated with the pieces.
Introduction
Samols et al. (1965) found that the administration of oral glucose resulted in increased levels of immunoreactive glucagon in the circulation and further studies suggested that this was of intestinal rather than pancreatie origin (Samols et al., 1966) . Unger et al. (1966) have confirmed the presence of immunoreaetive glueagon in the intestine and in a survey have found large amounts to be present in the jejunum, ileum and colon, with smaller amounts in the stomach and duodenum. This gut material differs from pancreatic glucagon in several respects, in that it is of larger molecular weight, is devoid of glycogenolytic activity and can differ in its reactions with antibodies against pancreatic glucagon (Valverde et al., 1970a; Valverde et al., 1970b) . For these reasons I2nger has coined the descriptive term 'glucagon-like immunoreaetivity' (GLI) to avoid confusion with pancreatic glueagon. Gut GLI has not as yet been purified and its biological properties remain largely unknown. Problems of specificity, degradation and sensitivity bedevil attempts to meaningfully interpret circulating blood levels of immunoreactive glueagon. For this reason an in vitro system for the study of gut GLI release would be useful and it is the purpose of this communication to describe a convenient model for studying the release of gut GLI from intestinal pieces which provides rapid and reliable data.
Materials and Methods

Assay Materials
Crystalline glucagon (Novo) was labelled with Iodine 1~ by a modification of the method of Greenwood et al. (1963) , and purified on finely precipitated silica (Quso G 32, Philadelphia Quartz Company). Separation of free from bound hormone was effectecl by dextran and horse serum (Burroughs Welleome No. 5) coated charcoal (Norit A) (Buchanan and MeCarroll, 1971) . Glueagon antibodies were produced in New Zealand white male rabbits by repeated injections of crystalline glucagon conjugated to crystalline egg albumin (Koch-Light). The animals were bled after the second and subsequent immunisations, and the sera processed for titre, affinity and specificity. The antisera used in these experiments were from a single animal (~ 57) and showed strong crossreaction with gut GLI of porcine and rat origin.
Preparation of Intestinal Pieces
A flow diagram for the procedure is shown in Fig. 1 . Albino Wistar rats (200--250 g) fed ad libitum were killed by a blow on the head. The intestine was immediately removed, the proximal 15 cm discarded and the next 50 em used in the studies. The intestinal lumen was washed with Krebs l%inger Bicarbonate (Kt~B) buffer and the intestine was then everted. One-em pieces were prepared and incubated in 1 ml of KRB buffer supplemented by 1% human albumin 1%. Zandomeneghi and K.D. Buchanan: Measuring the l~elease Diabetologia (Blood Products Laboratory), 5 mM EDTA, I000 KIU of Trasylol (FBA Pharmaceuticals), and excessive gincagon antibody. Some tubes were included without antibody to serve as non-specific controls in the subsequent glucagon assay. Materials which possibly affected the release or suppression of gut GLI and pancreatic glueagon standards were prepared in the same buffer. The pieces were incubated in stoppered glass tubes for 25 rain at 37~ in a metabolic bath with and the measurement of GLI immunoassay to tubes prepared with 100 ~1 glucagon I m5 (0.1--0.3 ng) and 1000 KIU Trasylol (100 izl) and 100 tA 40 mM phosphate buffer p}{ 7.4 with 2% horse serum. These tubes were then incubated at 4~ between 3 and 4 h before separation by charcoal. The charcoal precipitates were counted in a Panax autogamma counter, 15000 to 20000 counts being recorded in each sample. The percentage of counts bound to antibody was calculated and a plot of bound counts against glucagon concentration constructed for the glucagon standards. Gut GLI amounts were calculated from the standard curve and expressed as ng/ml pancreatic glucagon equivMents.
Results
The Glueagon Assay
A glucagon standard curve is shown in Fig. 2 . As incubations were performed in the presence of excess antibody in relationship to glucagon, maximum sen- Pancreatic glucagon standards in 100 ~.1 amounts were added to glucagon-free mucosal fluid to give final concentrations of 0--25 ng/ ml of glucagon. This 'glueagon-free' mucosal fluid was prepared by incubating rat intestine at 37~ for 1 h in KRB albumin buffer but without Trasylol, EDTA and antibody, and this resulted in the complete destruction of released glucagon. The glucagon standards in 'glucagon-free' mucosal fluid were incubated identically with intestinal pieces, and also supplemented by Trasylol, EDTA and antibody in similar concentrations as the intestinal pieces. After the 37~ incubation the tubes were rapidly removed to an ice bath, allowed to sit for 5 min to allow equilibration and duplicate 100 ~1 aliquots removed for glucagon radiositivity was achieved by shortening the optimum reaction time, (24 h) in the second incubation to 3--5 h. This resulted in between 35 and 45% binding of labelled glucagon in the absence of unlabe]led glueagon. This made possible the determination of 1 ng/ml of glucagon. Similar results were obtained in 'glucagonfree' mueosal fluid and KRB albumin buffer but incubation in mucosal fluid was preferred as it most closely resembled the conditions of the incubated intestinal pieces.
Recovery Studies
Because of the presence of multiple proteases in the intestinal mueosal ceils which rapidly destroy glucagon, methods had to be devised to prevent glucagon de-gradation. Trasylol, a known proteolytic inhibitor, and EDTA were found to be insufficient in themselves to give adequate recovery of added glucagon to the incubation medium. Therefore the method of Malaisse et al. (1967) which uses excessive insulin antibody to protect insulin from degradation in pancreatic incubates was modified for the present studies. Pancreatic glucagon in 100 ~1 amounts, calculated ~o give final concentrations of 10 and 14 ~g/ml of glucagon, were added to incubation tubes containing KRB, EDTA, gincagon antibody and intestinal pieces. Incubation was continued for 25 rain, along with tubes containing pieces but no added glucagon (basal tubes), and the standard curve tubes. The recovery of pancreatic glucagon added to the incubation tubes containing the intestinal pieces was calculated by subtracting the basal concentrations of released gut GLI from the concentrations when glucagon was added. The recoveries were for 10 ng/ml 92.5% =}=5.9 (n= 16) and for i4 ng/ml 9i.4% • 2.5 (n = 9) (mean ~ SEmi). The basal release was 2.74 ng/ml ~ 0.14 (n = 49). Prolonging the incubation beyond 25 rain resulted in poorer glucagon recoveries.
Glucose Concentration
Different concentrations of glucose were incubated with intestinal fluid to test their effect on gut GLI release and the results are shown in Fig. 3 . Highly significant increases in gut GLI were achieved using concentrations of glucose between 5 and 40 g%. In a further series of experiments the effect of lower concentrations of glucose was tried on gut GLI release. AT 1 g% glucose there was a highly significant gut GLI release (p < 0.001) when compared with tubes without glucose (0 glucose 0.99 =J= 0.19 ng/ml; 1 g% glucose 3.46 ~= 0.31 ng/ml) (mean ~= SEM). Although Mannitol at 20 and 40 g/100 ml produced a significant increase in gut GLI release, 3.84 4-0.16 ng/ml (p 0.01) and 3.63 _--4_-0.28 ng (p < 0.025)/ml respectively, compared with 2.74 • 0.14 ng/ml basal release, this was trivial compared with the glucose effects. The significant gut GLI response to 1 g/100 ml glucose would suggest that the GLI release may have physiological meaning. A simple osmotic effect appears unlikely from the Mannitol experiments. One g/100 ml glucose produced an absolute rise of 2.47 ng/ml GLI (250% basal) compared with only 0.89 ng/ml (132%) with 40 g/100 ml Mannitol.
Discussion
Luckyx and Lefcbvre (1968) described an in vitro technique for measuring the release of gut GLI. However they took no steps to prevent glucagon breakdown and do not report recovery studies. In our experience even incubation systems where the mucosal and serosal surface of the gut are bathed separately as in the everted intestinal sac (Wilson and Wiseman, 1954) result in rapid glucagon breakdown, suggesting that mucosal enzymes gain entry into the serosal fluid. The system of Luyckx and Lefebvre also suffers from lack of sensitivity caused mainly by the fact that gut GLI is released into a large incubation fluid volume o~ 5ml. The technique described in the present paper shows that by the use of Trasylol, EDTA and escessive antibody, glucagon breakdown can be prevented and satisfactory recoveries of added glucagon obtained. The glucagon is released into a 1 ml volume, allowing maximum sensitivity. Gassing of the incubating flasks was not found to be necessary.
The stimulation of gut GLI release by glucose is in agreement with the in vivo findings of the effect of oral glucose (Samols et al., 1965) , and suggests that the incubated intestinal pieces function satMaetorily. The technique is convenient and rapid and simple to perform, and appears to be an excellent model for studying the physiology and role of intestinal GLI. Such a model is of considerable importance because of the difficulties of interpretation of present glucagon radioimmunoassay methods in peripheral circulating blood. The method is currently being used in this laboratory to study factors which might influence gut GLI release.
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